Chinese Traditional and Herbal Drugs
|
2025, 56(6): 2171-2183
Research progress on mechanism of intestinal flora-based traditional Chinese medicine in treatment of hyperlipidemia
Full
ZHANG Junxia1,2, MA Jiaojiao1,2, LI Yanjie2, DONG Shiqi2, YANG Bin1, FAN Huirong2
Affiliations
1 Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;
2 Institute of Radiation Medicine, Chinese Academy of Medical Sciences, Tianjin 300192, China
doi: 10.7501/j.issn.0253-2670.2025.06.028
Outline
Hyperlipidemia is a common metabolic disease. Research indicates that the lipid-lowering efficacy of traditional Chinese medicine (TCM) is significantly linked to the modulation of intestinal microbiota, by enhancing the proliferation of beneficial probiotics, including Bacteroidetes and Bifidobacterium, which facilitate the release and absorption of pharmacological constituents, thereby contributing to lipid reduction. The intestinal flora has gradually become a new hotspot of research on the mechanism of lipid-lowering effect of TCM. However, the current lipid-lowering mechanism has not yet been fully elucidated, and most of the related studies focus on a single pathway or target, which fails to adequately represent the inherent advantages of TCM’s multi-target and multi-pathway approaches. Therefore, a more comprehensive exploration of the lipid-lowering mechanisms is warranted. In view of this, this article seeks to elucidate the synergistic interactions among TCM, intestinal flora, and the host. It aims to clarify the lipid-lowering mechanisms of Chinese medicine through the lens of intestinal flora, thereby offering novel insights and perspectives for advancing research in treatment of hyperlipidemia with TCM.
traditional Chinese medicine
/
hyperlipidemia
/
intestinal microbiota
/
lipid regulation
/
multi-targeting
/
lipid metabolism
张军霞, 马娇娇, 李艳杰, 董世奇, 杨彬, 樊慧蓉.
基于肠道菌群的中药治疗高脂血症作用机制研究进展.
中草药,
2025
, 56
(6)
: 2171
-2183
.
DOI: 10.7501/j.issn.0253-2670.2025.06.028
ZHANG Junxia, MA Jiaojiao, LI Yanjie, DONG Shiqi, YANG Bin, FAN Huirong.
Research progress on mechanism of intestinal flora-based traditional Chinese medicine in treatment of hyperlipidemia[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(6)
: 2171
-2183
.
DOI: 10.7501/j.issn.0253-2670.2025.06.028
Year 2025 volume 56 Issue 6
45
12
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.06.028
- Receive Date:2024-10-28
- Online Date:2026-11-13